1. World Health Organization. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Lung Cancer.
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
. Accessed 7 May 2017.
2. U.S. National Institutes of Health. National Cancer Institute: SEER Cancer Statistics Review, 1975–2012.
http://seer.cancer.gov/csr/1975_2012/browse_csr.php?sectionSEL=15&pageSEL=sect_15_table.28.html
. Accessed 7 May 2017.
3. Denoix P. Enquête permanente dans les centres anticancéreux. Bull Inst Natl Hyg. 1946;1:70–5.
4. Goldstraw P, Chansky K, Crowley J, et al. International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions.; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39–51.
5. Birley JD, Gospodarowicz M, Wittekind C, editors. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2016.